BG-102 is under clinical development by SL Bigen and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) indication ...

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.

Claims of higher energy density, much faster recharging, and better safety are why solid-state-battery technology appears to ...

Autopay is a convenient way to manage regular household bills. It’s simple. You authorize your creditor to take what’s due ...

The Movano Hydrogen benefits from more than 20 years of knowledge in the development of Hydrogen fuel cell vehicles at ...

Fortnite is a fast-paced shooter, but it's easy to forget its competitive nature while looking at the bright visual style. However, crossovers with John Wick an ...

Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for ...

NAGOYA--The operator of the Tokaido Shinkansen Line plans to install next-generation, thin solar cells on noise barriers ...

Dior has named Oscar-winning actress and long-term ambassador Charlize Theron as the face of its reinvented Dior Capture line ...

Innovent Biologics (IVBIY) secures second Chinese approval for lung cancer therapy Dovbleron developed with U.S. biotech ...

Why does radical feminist art pose such a danger to political power, and what can these artistic strategies achieve in ...